Related Experiment Video
Updated: Aug 12, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary
Rakendra Singh1, Sanjeev Kumar Singla2, Ankush Singla2
1Department of Medicine, Adesh Institute of Medical Sciences and Research Bhatinda, Punjab, India.
Insights
Catheter-directed intracoronary thrombolysis (ICT) effectively reduces thrombus burden in ST-elevation myocardial infarction (STEMI) patients experiencing no-reflow. This life-saving treatment improves myocardial reperfusion with minimal side effects.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Coronary Syndromes
Background:
- Intracoronary thrombus is a frequent complication in ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI).
- Large thrombus burden can lead to embolization and a no-reflow state, increasing infarct size and mortality.
- Catheter-directed intracoronary thrombolysis (ICT) is emerging as a strategy for managing no-reflow due to significant thrombus.
Purpose of the Study:
- To evaluate the efficacy and safety of catheter-directed ICT in STEMI patients with no-reflow.
- To assess the impact of ICT on thrombus burden and myocardial reperfusion.
Main Methods:
- Retrospective observational study of 1020 adult patients.
- Focus on 10% of patients with acute STEMI undergoing PCI with no-reflow.
- ICT administered using low-dose tenecteplase (15 ± 5 mg).
Main Results:
- Thrombolysis in Myocardial Infarction (TIMI) flow Grade 5 in 79.17% and Grade 4 in 20.83% prior to ICT.
- TIMI flow Grade III achieved in 91.67% and Grade II in 8.33% post-ICT.
- Major risk factor: tobacco smoking (41.67%). Major complication: left ventricular failure (33.33%).
Conclusions:
- Catheter-directed ICT is a safe and effective treatment for reducing thrombus burden in STEMI.
- ICT improves myocardial reperfusion and can be life-saving in no-reflow states.
- This intervention offers a valuable option with minimal systemic side effects for managing complex STEMI cases.
Background:
Intracoronary thrombus is common in patients with ST-elevation myocardial infarction (STEMI). Percutaneous coronary intervention (PCI) is the treatment of choice for these patients. Intracoronary thrombus is still a challenge during PCI in STEMI, even with dual antiplatelets, glycoprotein IIb/IIIa inhibitor, and anticoagulation. Intracoronary thrombus can cause distal or nonculprit vessel embolization and no-reflow state. No reflow results in large infarct size, adverse left ventricular remodeling, arrhythmias, and death. Recently, catheter-directed intracoronary thrombolysis (ICT) is gaining acceptance in patients with no-reflow due to a large thrombus burden.
Aim:
Evaluation of catheter-directed ICT in patients with acute STEMI who develop no reflow due to large thrombus burden during PCI.
Materials And Methods And Results:
This was a retrospective observational study conducted after approval of the institutional ethics committee in a tertiary care hospital of north India from April 15, 2021 to April 14, 2022, included 1020 adult patients who had undergone coronary evaluation. 37.25% patients had PCI, among these 10% had PCI for acute STEMI. Thrombolysis in myocardial infarction (TIMI) Grade 5 in 79.17% and Grade 4 in 20.83%. ICT was done with low-dose tenecteplase (15 ± 5 mg). The TIMI flow III in 91.67% and II in 8.33% of patients was achieved after intracoronary thrombolysis. Major risk factor was tobacco smoking in 41.67%, and the major complication was left ventricular failure in 33.33%.
Conclusions:
Catheter-directed ICT is safe and effective in reducing thrombus burden, thus improving myocardial reperfusion in STEMI. This condition has a grave prognosis and can lead to adverse cardiac outcomes. There are many drugs that have been tried to manage no reflow. The use of ICT to treat no-reflow state can be life saving with minimal systemic side effects.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Angina IV: Management
Acute Coronary Syndrome I: Introduction
Cardiac Catheterization IV: Nursing Management